Results 201 to 210 of about 31,457 (263)

Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study. [PDF]

open access: yesJ Clin Med
Ausín P   +8 more
europepmc   +1 more source

The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma. [PDF]

open access: yesJ Asthma Allergy
Rimkunas A   +6 more
europepmc   +1 more source

Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries

open access: yesClinical &Experimental Allergy, EarlyView.
There is a tight intersection between asthma, deprivation, ethnicity, multimorbidity and poor clinical outcomes. An integrated, holistic and culturally tailored approach is needed to improve clinical outcomes amongst ethnic minority groups with asthma and multimorbidity. ABSTRACT Asthma is one of the commonest noncommunicable diseases worldwide.
Mamidipudi Thirumala Krishna   +6 more
wiley   +1 more source

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment. [PDF]

open access: yesWorld Allergy Organ J
Pham DD   +28 more
europepmc   +1 more source

Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi study. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Bachert C   +10 more
europepmc   +1 more source

Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? [PDF]

open access: yesTuberk Toraks
Açar E   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy